TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

Historical Holders from Q3 2021 to Q1 2025

Symbol
TCRX on Nasdaq
CUSIP
89854M101
Type / Class
Equity / Voting Common Stock, $0.0001 par value per share
Shares outstanding
52.2M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
41.5M
Holdings value
$126M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
88
Number of buys
41
Number of sells
-31
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Lynx1 Capital Management LP 10.9% $9.59M 5.36M Lynx1 Capital Management LP Dec 31, 2024
K2 HealthVentures Equity Trust LLC 6.9% $6.45M 3.6M K2 HealthVentures Equity Trust LLC Dec 31, 2024
ADAGE CAPITAL PARTNERS GP, L.L.C. 7.13% $6.27M 3.5M Adage Capital Management, L.P. Dec 31, 2024

Institutional Holders of TScan Therapeutics, Inc. - Voting Common Stock, $0.0001 par value per share (TCRX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 73.7K $102K -$5.12K $1.38 4
2024 Q4 41.5M $126M -$5.95M $3.04 88
2024 Q3 41.8M $208M +$256K $4.98 86
2024 Q2 41.4M $242M +$40.5M $5.85 78
2024 Q1 34.3M $272M +$19.2M $7.94 65
2023 Q4 31.9M $186M +$7.36M $5.83 54
2023 Q3 28.6M $73.2M +$2.18M $2.56 32
2023 Q2 28M $69.9M +$45.8M $2.50 28
2023 Q1 9.65M $20.3M +$610K $2.10 27
2022 Q4 9.52M $14.8M -$121K $1.55 28
2022 Q3 9.51M $29M -$531K $3.05 24
2022 Q2 9.68M $30.4M +$1.53M $3.14 23
2022 Q1 9.37M $26.2M -$1.53M $2.80 23
2021 Q4 9.86M $44.4M -$2.46M $4.50 28
2021 Q3 10.1M $83.5M +$83.5M $8.34 26